Work

Further Optimizing Care of Patients With Operable Hormone Receptor–Sensitive Breast Cancer

Year: 2024

Type: editorial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.24.01080

Authors: Alexandra Thomas, Erica L. Mayer, Angela DeMichele, Nadia Harbeck, Giuseppe Curigliano, Michail Ignatiadis, Virginie Adam, Yang Zhou, Thelma P. Brown, Leslie Gilham, Boon H. Chua, Kevin Kalinsky, Antonio C. Wolff, Seamus O'Reilly

Institutions: Duke University, Duke Cancer Institute, Dana-Farber Cancer Institute, Abramson Cancer Center, University of Pennsylvania, LMU Klinikum, Ludwig-Maximilians-Universität München, European Institute of Oncology, Institut Jules Bordet, Breast International Group, Yale Cancer Center, University of Alabama at Birmingham, Breast Cancer Trials, UNSW Sydney, Winship Cancer Institute, Johns Hopkins University, Johns Hopkins Medicine, Sidney Kimmel Comprehensive Cancer Center, Cancer Trials Ireland

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Health Research Board

Award: G8890405749

OpenAlex ID: W4403267180

Cites: 33

Cited by: 2

Related to: 10